Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy – an analysis of the DiaRegis registry

BACKGROUND: Type-2 diabetes mellitus has a major impact on health related quality of life (HRQoL). We aimed to identify patient and treatment related variables having a major impact. METHODS: DiaRegis is a prospective diabetes registry. The EQ-5D was used to describe differences in HRQoL at baseline...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasem, Jürgen, Bramlage, Peter, Gitt, Anselm K, Binz, Christiane, Krekler, Michael, Deeg, Evelin, Tschöpe, Diethelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606825/
https://www.ncbi.nlm.nih.gov/pubmed/23510200
http://dx.doi.org/10.1186/1475-2840-12-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606825/
https://www.ncbi.nlm.nih.gov/pubmed/23510200
http://dx.doi.org/10.1186/1475-2840-12-47

Ejemplares similares